OTCMKTS:IPHYF - Innate Pharma Price Target & Analyst Ratings

$7.02
0.00 (0.00 %)
(As of 06/24/2019 06:00 AM ET)
Today's Range
$7.02
Now: $7.02
$7.02
50-Day Range
$6.39
MA: $6.70
$7.25
52-Week Range
$5.07
Now: $7.02
$10.40
Volume75 shs
Average Volume111 shs
Market Capitalization$404.35 million
P/E RatioN/A
Dividend YieldN/A
Beta0.03

Analyst Ratings

Innate Pharma (OTCMKTS:IPHYF) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Innate Pharma in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Innate Pharma (OTCMKTS:IPHYF) Consensus Price Target History

Price Target History for Innate Pharma (OTCMKTS:IPHYF)

Innate Pharma (OTCMKTS:IPHYF) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
9/17/2018HC WainwrightReiterated RatingBuyView Rating Details
6/14/2018Leerink SwannReiterated RatingOutperformView Rating Details
(Data available from 6/24/2017 forward)
This page was last updated on 6/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel